In recent years, many studies have shown that PLAUR can be an effective prognostic biomarker and potential therapeutic target for GC due to the fact that the suppression of PLAUR could sensitize cancer cell death by inducing DNA damages (Li et al., 2013a; Ai et al., 2020). This evidence concerns the gene PLAUR and cancer.